| nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
| 1 |
A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: Results of a randomised, controlled, dose-escalation phase 1 trial
|
Richmond, P.C.
|
|
2012
|
30 |
Supplement 1 |
p. 6163-6174
12 p.
|
artikel
|
| 2 |
Acceptability of human papillomavirus vaccination and sexual experience prior to disclosure to health care providers among men who have sex with men in Vancouver, Canada: Implications for targeted vaccination programs
|
Rank, Claudia
|
|
2012
|
30 |
Supplement 1 |
p. 5755-5760
6 p.
|
artikel
|
| 3 |
A cell culture-derived whole-virus H5N1 vaccine induces long-lasting cross-clade protective immunity in mice which is augmented by a homologous or heterologous booster vaccination
|
Sabarth, Nicolas
|
|
2012
|
30 |
Supplement 1 |
p. 5533-5540
8 p.
|
artikel
|
| 4 |
A cluster of nonspecific adverse events in a military reserve unit following pandemic influenza A (H1N1) 2009 vaccination—Possible stimulated reporting?
|
McNeil, Michael M.
|
|
2012
|
30 |
Supplement 1 |
p. 2421-2426
6 p.
|
artikel
|
| 5 |
A collaborative approach to investigating the risk of thrombocytopenic purpura after measles–mumps–rubella vaccination in England and Denmark
|
Andrews, Nick
|
|
2012
|
30 |
Supplement 1 |
p. 3042-3046
5 p.
|
artikel
|
| 6 |
Acute exercise enhancement of pneumococcal vaccination response: A randomised controlled trial of weaker and stronger immune response
|
Edwards, Kate M.
|
|
2012
|
30 |
Supplement 1 |
p. 6389-6395
7 p.
|
artikel
|
| 7 |
A designed Tat immunogen generates enhanced anti-Tat C-terminal antibodies
|
Liao, Wenting
|
|
2012
|
30 |
Supplement 1 |
p. 2453-2461
9 p.
|
artikel
|
| 8 |
Adjuvant effect of Japanese herbal medicines on the mucosal type 1 immune responses to human papillomavirus (HPV) E7 in mice immunized orally with Lactobacillus-based therapeutic HPV vaccine in a synergistic manner
|
Taguchi, Ayumi
|
|
2012
|
30 |
Supplement 1 |
p. 5368-5372
5 p.
|
artikel
|
| 9 |
A dose-escalation safety and immunogenicity study of a new live attenuated human rotavirus vaccine (Rotavin-M1) in Vietnamese children
|
Anh, Dang Duc
|
|
2012
|
30 |
Supplement 1 |
p. A114-A121
nvt p.
|
artikel
|
| 10 |
Adverse events following immunization during mass vaccination campaigns at first introduction of a meningococcal A conjugate vaccine in Burkina Faso, 2010
|
Ouandaogo, Claude-Roger
|
|
2012
|
30 |
Supplement 1 |
p. B46-B51
nvt p.
|
artikel
|
| 11 |
Alum-adjuvanted H5N1 whole virion inactivated vaccine (WIV) enhanced inflammatory cytokine productions
|
Nakayama, Tetsuo
|
|
2012
|
30 |
Supplement 1 |
p. 3885-3890
6 p.
|
artikel
|
| 12 |
An engineered mutant of HIV-1 gp120 formulated with adjuvant Quil A promotes elicitation of antibody responses overlapping the CD4-binding site
|
Ahmed, Fatima K.
|
|
2012
|
30 |
Supplement 1 |
p. 922-930
9 p.
|
artikel
|
| 13 |
An HIVgp41 vaccine protects CD4 central memory T cells in SHIV-infected macaques
|
Vieillard, Vincent
|
|
2012
|
30 |
Supplement 1 |
p. 6883-6891
9 p.
|
artikel
|
| 14 |
An open-label, randomized, multi-center study of the immunogenicity and safety of DTaP–IPV (Kinrix™) co-administered with MMR vaccine with or without varicella vaccine in healthy pre-school age children
|
Klein, Nicola P.
|
|
2012
|
30 |
Supplement 1 |
p. 668-674
7 p.
|
artikel
|
| 15 |
A novel adjuvant, mixture of alum and the beta-adrenergic receptor antagonist propranolol, elicits both humoral and cellular immune responses for heat-killed Salmonella typhimurium vaccine
|
Mazloomi, Ebrahim
|
|
2012
|
30 |
Supplement 1 |
p. 2640-2646
7 p.
|
artikel
|
| 16 |
A novel self-assembled nanoparticle vaccine with HIV-1 Tat49-57/HPV16 E749-57 fusion peptide and GM-CSF DNA elicits potent and prolonged CD8+ T cell-dependent anti-tumor immunity in mice
|
Tang, Jun
|
|
2012
|
30 |
Supplement 1 |
p. 1071-1082
12 p.
|
artikel
|
| 17 |
Antibiotic resistance and serotype distribution of invasive pneumococcal diseases before and after introduction of pneumococcal conjugate vaccine in the Kingdom of Saudi Arabia (KSA)
|
Shibl, Atef M.
|
|
2012
|
30 |
Supplement 1 |
p. G32-G36
nvt p.
|
artikel
|
| 18 |
Antibody response to allelic variants of 19kDa fragment of MSP-1: Recognition of a variant and protection associated with ethnicity in Assam, India
|
Lourembam, Sonia D.
|
|
2012
|
30 |
Supplement 1 |
p. 767-773
7 p.
|
artikel
|
| 19 |
An unmasking phenomenon in an observational post-licensure safety study of adolescent girls and young women
|
Jacobsen, Steven J.
|
|
2012
|
30 |
Supplement 1 |
p. 4585-4587
3 p.
|
artikel
|
| 20 |
An update on human papillomavirus vaccine uptake among 11–17 year old girls in the United States: National Health Interview Survey, 2010
|
Laz, Tabassum H.
|
|
2012
|
30 |
Supplement 1 |
p. 3534-3540
7 p.
|
artikel
|
| 21 |
A Phase 1 clinical trial of Hantaan virus and Puumala virus M-segment DNA vaccines for hemorrhagic fever with renal syndrome
|
Boudreau, Ellen F.
|
|
2012
|
30 |
Supplement 1 |
p. 1951-1958
8 p.
|
artikel
|
| 22 |
A phase 3, randomized, double-blind trial comparing the safety and immunogenicity of the 7-valent and 13-valent pneumococcal conjugate vaccines, given with routine pediatric vaccinations, in healthy infants in Brazil
|
Weckx, Lily Yin
|
|
2012
|
30 |
Supplement 1 |
p. 7566-7572
7 p.
|
artikel
|
| 23 |
A predictive value of quantitative HBsAg for serum HBV DNA level among HBeAg-positive pregnant women
|
Sun, Kui-Xia
|
|
2012
|
30 |
Supplement 1 |
p. 5335-5340
6 p.
|
artikel
|
| 24 |
A randomised, single-blind, dose-range study to assess the immunogenicity and safety of a cell-culture-derived A/H1N1 influenza vaccine in adult and elderly populations
|
Hatz, Christoph
|
|
2012
|
30 |
Supplement 1 |
p. 4820-4827
8 p.
|
artikel
|
| 25 |
A retrospective epidemiological study of invasive pneumococcal infections in children aged 0–5 years in Bahrain from 1 January 1999 to 31 December 2003
|
Al Musawi, Muna
|
|
2012
|
30 |
Supplement 1 |
p. G2-G6
nvt p.
|
artikel
|
| 26 |
Ascaris suum enolase is a potential vaccine candidate against ascariasis
|
Chen, Ning
|
|
2012
|
30 |
Supplement 1 |
p. 3478-3482
5 p.
|
artikel
|
| 27 |
A single-dose cytomegalovirus-based vaccine encoding tetanus toxin fragment C induces sustained levels of protective tetanus toxin antibodies in mice
|
Tierney, Rob
|
|
2012
|
30 |
Supplement 1 |
p. 3047-3052
6 p.
|
artikel
|
| 28 |
Assessing the immunological response to hepatitis B vaccination in HIV-infected patients in clinical practice
|
Mena, Guillermo
|
|
2012
|
30 |
Supplement 1 |
p. 3703-3709
7 p.
|
artikel
|
| 29 |
Assessment of the cross-protective capability of recombinant capsid proteins derived from pig, rat, and avian hepatitis E viruses (HEV) against challenge with a genotype 3 HEV in pigs
|
Sanford, Brenton J.
|
|
2012
|
30 |
Supplement 1 |
p. 6249-6255
7 p.
|
artikel
|
| 30 |
Association of polymorphisms of cytokine and TLR-2 genes with long-term immunity to hepatitis B in children vaccinated early in life
|
Wang, Yangyang
|
|
2012
|
30 |
Supplement 1 |
p. 5708-5713
6 p.
|
artikel
|
| 31 |
A strategy of antigen incorporation into exosomes: Comparing cross-presentation levels of antigens delivered by engineered exosomes and by lentiviral virus-like particles
|
Lattanzi, Laura
|
|
2012
|
30 |
Supplement 1 |
p. 7229-7237
9 p.
|
artikel
|
| 32 |
A US postmarketing evaluation of the frequency and safety of live attenuated influenza vaccine use in nonrecommended children younger than 5 years: 2009–2010 season
|
Tennis, Patricia
|
|
2012
|
30 |
Supplement 1 |
p. 6099-6102
4 p.
|
artikel
|
| 33 |
Autoimmune disorders after immunisation with Influenza A/H1N1 vaccines with and without adjuvant: EudraVigilance data and literature review
|
Isai, Alina
|
|
2012
|
30 |
Supplement 1 |
p. 7123-7129
7 p.
|
artikel
|
| 34 |
A varicella outbreak in a school with high one-dose vaccination coverage, Beijing, China
|
Lu, Li
|
|
2012
|
30 |
Supplement 1 |
p. 5094-5098
5 p.
|
artikel
|
| 35 |
Avian paramyxovirus serotypes 2-9 (APMV-2-9) vary in the ability to induce protective immunity in chickens against challenge with virulent Newcastle disease virus (APMV-1)
|
Nayak, Baibaswata
|
|
2012
|
30 |
Supplement 1 |
p. 2220-2227
8 p.
|
artikel
|
| 36 |
Avian reovirus sigma C enhances the mucosal and systemic immune responses elicited by antigen-conjugated lactic acid bacteria
|
Lin, Kuan-Hsun
|
|
2012
|
30 |
Supplement 1 |
p. 5019-5029
11 p.
|
artikel
|
| 37 |
Barriers to HPV immunization for African American adolescent females
|
Hamlish, Tamara
|
|
2012
|
30 |
Supplement 1 |
p. 6472-6476
5 p.
|
artikel
|
| 38 |
Baseline hepatitis B vaccination coverage among persons with diabetes before implementing a U.S. recommendation for vaccination
|
Byrd, Kathy K.
|
|
2012
|
30 |
Supplement 1 |
p. 3376-3382
7 p.
|
artikel
|
| 39 |
Blockade of B7-H1 enhances dendritic cell-mediated T cell response and antiviral immunity in HBV transgenic mice
|
Jiang, Wenzheng
|
|
2012
|
30 |
Supplement 1 |
p. 758-766
9 p.
|
artikel
|
| 40 |
Bovine tuberculosis vaccine research: Historical perspectives and recent advances
|
Waters, W. Ray
|
|
2012
|
30 |
Supplement 1 |
p. 2611-2622
12 p.
|
artikel
|
| 41 |
Broad HIV-1 neutralizing antibody response induced by heterologous gp140/gp145 DNA prime-vaccinia boost immunization
|
Liu, Lianxing
|
|
2012
|
30 |
Supplement 1 |
p. 4135-4143
9 p.
|
artikel
|
| 42 |
Canine rabies vaccination and domestic dog population characteristics in the developing world: A systematic review
|
Davlin, Stacy L.
|
|
2012
|
30 |
Supplement 1 |
p. 3492-3502
11 p.
|
artikel
|
| 43 |
Capsule null locus meningococci: Typing of antigens used in an investigational multicomponent meningococcus serogroup B vaccine
|
Claus, Heike
|
|
2012
|
30 |
Supplement 1 |
p. 155-160
6 p.
|
artikel
|
| 44 |
Cationic liposome–DNA complexes (CLDC) adjuvant enhances the immunogenicity and cross-protective efficacy of a pre-pandemic influenza A H5N1 vaccine in mice
|
Dong, Libo
|
|
2012
|
30 |
Supplement 1 |
p. 254-264
11 p.
|
artikel
|
| 45 |
Cell culture (Vero cell) derived whole-virus non-adjuvanted H5N1 influenza vaccine induces long-lasting cross-reactive memory immune response: Homologous or heterologous booster response following two dose or single dose priming
|
van der Velden, Maikel V.W.
|
|
2012
|
30 |
Supplement 1 |
p. 6127-6135
9 p.
|
artikel
|
| 46 |
Challenges in confirming a varicella outbreak in the two-dose vaccine era
|
Mahamud, Abdirahman
|
|
2012
|
30 |
Supplement 1 |
p. 6935-6939
5 p.
|
artikel
|
| 47 |
Challenge with a hepatitis B vaccine in two cohorts of 4–7-year-old children primed with hexavalent vaccines: An open-label, randomised trial in Italy
|
Zanetti, Alessandro
|
|
2012
|
30 |
Supplement 1 |
p. 5770-5775
6 p.
|
artikel
|
| 48 |
Changes in seroprevalence to hepatitis A in Victoria, Australia: A comparison of three time points
|
Heywood, A.E.
|
|
2012
|
30 |
Supplement 1 |
p. 6020-6026
7 p.
|
artikel
|
| 49 |
Changes in the composition of the pneumococcal population and in IPD incidence in The Netherlands after the implementation of the 7-valent pneumococcal conjugate vaccine
|
Elberse, Karin E.M.
|
|
2012
|
30 |
Supplement 1 |
p. 7644-7651
8 p.
|
artikel
|
| 50 |
Changing epidemiology of pediatric Streptococcus pneumoniae isolates before vaccine introduction in Casablanca (Morocco)
|
Elmdaghri, Naima
|
|
2012
|
30 |
Supplement 1 |
p. G46-G50
nvt p.
|
artikel
|
| 51 |
Characterizing providers’ immunization communication practices during health supervision visits with vaccine-hesitant parents: A pilot study
|
Opel, Douglas J.
|
|
2012
|
30 |
Supplement 1 |
p. 1269-1275
7 p.
|
artikel
|
| 52 |
Children with otitis media mount a pneumococcal serotype specific serum IgG and IgA response comparable to healthy controls after pneumococcal conjugate vaccination
|
Menon, Vinay J.
|
|
2012
|
30 |
Supplement 1 |
p. 3136-3144
9 p.
|
artikel
|
| 53 |
Clinical study of transcutaneous vaccination using a hydrogel patch for tetanus and diphtheria
|
Hirobe, Sachiko
|
|
2012
|
30 |
Supplement 1 |
p. 1847-1854
8 p.
|
artikel
|
| 54 |
Codon changed immobilization antigen (iAg), a potent DNA vaccine in fish against Cryptocaryon irritans infection
|
Jose Priya, T.A.
|
|
2012
|
30 |
Supplement 1 |
p. 893-903
11 p.
|
artikel
|
| 55 |
Comparative immunogenicity and safety of different multivalent component pertussis vaccine formulations and a 5-component acellular pertussis vaccine in infants and toddlers: A randomized, controlled, open-label, multicenter study
|
Chatterjee, Archana
|
|
2012
|
30 |
Supplement 1 |
p. 3360-3368
9 p.
|
artikel
|
| 56 |
Comparative seroepidemiology of pertussis, diphtheria and poliovirus antibodies in Singapore: Waning pertussis immunity in a highly immunized population and the need for adolescent booster doses
|
Lai, F.Y.
|
|
2012
|
30 |
Supplement 1 |
p. 3566-3571
6 p.
|
artikel
|
| 57 |
Conservation of HIV-1 T cell epitopes across time and clades: Validation of immunogenic HLA-A2 epitopes selected for the GAIA HIV vaccine
|
Levitz, Lauren
|
|
2012
|
30 |
Supplement 1 |
p. 7547-7560
14 p.
|
artikel
|
| 58 |
Construction and characterization of human rotavirus recombinant VP8* subunit parenteral vaccine candidates
|
Wen, Xiaobo
|
|
2012
|
30 |
Supplement 1 |
p. 6121-6126
6 p.
|
artikel
|
| 59 |
Cost-effectiveness of hepatitis A vaccination for adults in Belgium
|
Luyten, Jeroen
|
|
2012
|
30 |
Supplement 1 |
p. 6070-6080
11 p.
|
artikel
|
| 60 |
Cost-effectiveness of potential infant vaccination against respiratory syncytial virus infection in The Netherlands
|
Meijboom, M.J.
|
|
2012
|
30 |
Supplement 1 |
p. 4691-4700
10 p.
|
artikel
|
| 61 |
Current epidemiology of rubella and congenital rubella syndrome in Australia: Progress towards elimination
|
Song, Ning
|
|
2012
|
30 |
Supplement 1 |
p. 4073-4078
6 p.
|
artikel
|
| 62 |
Current issues with the immunization program in Japan: Can we fill the “vaccine gap”?
|
Saitoh, Akihiko
|
|
2012
|
30 |
Supplement 1 |
p. 4752-4756
5 p.
|
artikel
|
| 63 |
Delivery of antigenic candidates by a DNA/MVA heterologous approach elicits effector CD8+T cell mediated immunity against Trypanosoma cruzi
|
Gupta, Shivali
|
|
2012
|
30 |
Supplement 1 |
p. 7179-7186
8 p.
|
artikel
|
| 64 |
Design and immunological properties of Helicobacter pylori glycoconjugates based on a truncated lipopolysaccharide lacking Lewis antigen and comprising an α-1,6-glucan chain
|
Altman, Eleonora
|
|
2012
|
30 |
Supplement 1 |
p. 7332-7341
10 p.
|
artikel
|
| 65 |
Differential effects of monophosphoryl lipid A and cytokine cocktail as maturation stimuli of immunogenic and tolerogenic dendritic cells for immunotherapy
|
Raïch-Regué, Dàlia
|
|
2012
|
30 |
Supplement 1 |
p. 378-387
10 p.
|
artikel
|
| 66 |
Disability among US Army Veterans vaccinated against anthrax
|
Sulsky, Sandra I.
|
|
2012
|
30 |
Supplement 1 |
p. 6150-6156
7 p.
|
artikel
|
| 67 |
Do income inequality and social capital associate with measles-containing vaccine coverage rate?
|
Nagaoka, Kei
|
|
2012
|
30 |
Supplement 1 |
p. 7481-7488
8 p.
|
artikel
|
| 68 |
Early infection dynamics after experimental challenge with Mycobacterium avium subspecies paratuberculosis in calves reveal limited calf-to-calf transmission and no impact of Hsp70 vaccination
|
Santema, Wiebren J.
|
|
2012
|
30 |
Supplement 1 |
p. 7032-7039
8 p.
|
artikel
|
| 69 |
Early-life and contemporaneous nutritional and environmental predictors of antibody response to vaccination in young Gambian adults
|
Moore, Sophie E.
|
|
2012
|
30 |
Supplement 1 |
p. 4842-4848
7 p.
|
artikel
|
| 70 |
Economic analysis for evidence-based policy-making on a national immunization program: A case of rotavirus vaccine in Thailand
|
Muangchana, Charung
|
|
2012
|
30 |
Supplement 1 |
p. 2839-2847
9 p.
|
artikel
|
| 71 |
Economic evaluation of vaccination programme of 7-valent pneumococcal conjugate vaccine to the birth cohort in Japan
|
Hoshi, Shu-ling
|
|
2012
|
30 |
Supplement 1 |
p. 3320-3328
9 p.
|
artikel
|
| 72 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 1 |
p. IFC-
1 p.
|
artikel
|
| 73 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 74 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 75 |
Editorial Board
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 76 |
Editorial Board/Aims and Scope
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 77 |
Editorial Board/Aims and Scope
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 78 |
Editorial Board/Aims and Scope
|
|
|
2012
|
30 |
Supplement 1 |
p. CO2-
1 p.
|
artikel
|
| 79 |
Effectively introducing a new meningococcal A conjugate vaccine in Africa: The Burkina Faso experience
|
Djingarey, Mamoudou H.
|
|
2012
|
30 |
Supplement 1 |
p. B40-B45
nvt p.
|
artikel
|
| 80 |
Effectiveness and cost-effectiveness of pediatric rotavirus vaccination in British Columbia: A model-based evaluation
|
Fisman, David N.
|
|
2012
|
30 |
Supplement 1 |
p. 7601-7607
7 p.
|
artikel
|
| 81 |
Effectiveness of mouse brain-derived inactivated Japanese encephalitis vaccine in Thai National Immunization Program: A case–control study
|
Muangchana, Charung
|
|
2012
|
30 |
Supplement 1 |
p. 361-367
7 p.
|
artikel
|
| 82 |
Effectiveness of the monovalent AS03-adjuvanted influenza A(H1N1)pdm09 vaccine against hospitalization in children because of influenza
|
Örtqvist, Åke
|
|
2012
|
30 |
Supplement 1 |
p. 5699-5702
4 p.
|
artikel
|
| 83 |
Effect of age and frequency of injections on immune response to hepatitis B vaccination in drug users
|
Tran, Thanh Q.
|
|
2012
|
30 |
Supplement 1 |
p. 342-349
8 p.
|
artikel
|
| 84 |
Effect of needle length for response to hepatitis B vaccine in macrosomic neonates: A prospective randomized study
|
Ozdemir, Ramazan
|
|
2012
|
30 |
Supplement 1 |
p. 3155-3158
4 p.
|
artikel
|
| 85 |
Effect of vaccination with an inactivated vaccine on transplacental transmission of BTV-8 in mid term pregnant ewes and heifers
|
van der Sluijs, M.T.W.
|
|
2012
|
30 |
Supplement 1 |
p. 647-655
9 p.
|
artikel
|
| 86 |
Effects of immunization with natural and recombinant lysine decarboxylase on canine gingivitis development
|
Peters, Jennifer L.
|
|
2012
|
30 |
Supplement 1 |
p. 6706-6712
7 p.
|
artikel
|
| 87 |
Efficacy and immunogenicity of two or three dose rotavirus-vaccine regimen in South African children over two consecutive rotavirus-seasons: A randomized, double-blind, placebo-controlled trial
|
Madhi, S.A.
|
|
2012
|
30 |
Supplement 1 |
p. A44-A51
nvt p.
|
artikel
|
| 88 |
Efficacy of a reformulated inactivated chimeric PCV1-2 vaccine based on clinical, virological, pathological and immunological examination under field conditions
|
Seo, Hwi Won
|
|
2012
|
30 |
Supplement 1 |
p. 6671-6677
7 p.
|
artikel
|
| 89 |
Efficacy of human rotavirus vaccine against severe gastroenteritis in Malawian children in the first two years of life: A randomized, double-blind, placebo controlled trial
|
Cunliffe, Nigel A.
|
|
2012
|
30 |
Supplement 1 |
p. A36-A43
nvt p.
|
artikel
|
| 90 |
Efficacy of the oral pentavalent rotavirus vaccine in Mali
|
Sow, Samba O.
|
|
2012
|
30 |
Supplement 1 |
p. A71-A78
nvt p.
|
artikel
|
| 91 |
Efficient extraction of vaccines formulated in aluminum hydroxide gel by including surfactants in the extraction buffer
|
Zhu, Daming
|
|
2012
|
30 |
Supplement 1 |
p. 189-194
6 p.
|
artikel
|
| 92 |
Eliciting broad neutralizing antibody to HIV-1: Envelopes of different lentivirus cross immunization by prime-boost vaccination
|
Luo, Zhenwu
|
|
2012
|
30 |
Supplement 1 |
p. 5316-5323
8 p.
|
artikel
|
| 93 |
Enhancement of protective immunity against intracellular bacteria using type-1 polarized dendritic cell (DC) vaccine
|
Kono, Masato
|
|
2012
|
30 |
Supplement 1 |
p. 2633-2639
7 p.
|
artikel
|
| 94 |
Epidemiology of invasive pneumococcal infection among hospitalized children aged less than 5 years in Oman
|
Awaidy, Salah Thabit Al
|
|
2012
|
30 |
Supplement 1 |
p. G7-G10
nvt p.
|
artikel
|
| 95 |
Epstein–Barr virus genome load is increased by therapeutic vaccination in HIV-l carriers, and further enhanced in patients with a history of symptomatic primary infection
|
Friis, Anna M.C.
|
|
2012
|
30 |
Supplement 1 |
p. 6093-6098
6 p.
|
artikel
|
| 96 |
Estimating the age-specific duration of herpes zoster vaccine protection: A matter of model choice?
|
Bilcke, Joke
|
|
2012
|
30 |
Supplement 1 |
p. 2795-2800
6 p.
|
artikel
|
| 97 |
Evaluation of a toolkit to introduce standing orders for influenza and pneumococcal vaccination in adults: A multimodal pilot project
|
Nowalk, Mary Patricia
|
|
2012
|
30 |
Supplement 1 |
p. 5978-5982
5 p.
|
artikel
|
| 98 |
Evaluation of attenuated VSVs with mutated M or/and G proteins as vaccine vectors
|
Fang, Xinkui
|
|
2012
|
30 |
Supplement 1 |
p. 1313-1321
9 p.
|
artikel
|
| 99 |
Evaluation of cost-effectiveness of live oral pentavalent reassortant rotavirus vaccine introduction in Ghana
|
Abbott, Collette
|
|
2012
|
30 |
Supplement 1 |
p. 2582-2587
6 p.
|
artikel
|
| 100 |
Evaluation of meningococcal serogroup C conjugate vaccine programs in Canadian children: Interim analysis
|
Bettinger, Julie A.
|
|
2012
|
30 |
Supplement 1 |
p. 4023-4027
5 p.
|
artikel
|
| 101 |
Evaluation of protective effect of DNA vaccines encoding the BAB1_0263 and BAB1_0278 open reading frames of Brucella abortus in BALB/c mice
|
Sislema-Egas, Fernanda
|
|
2012
|
30 |
Supplement 1 |
p. 7286-7291
6 p.
|
artikel
|
| 102 |
Evolution of immune response against Neisseria meningitidis B:14:P1.7,16 before and after the outer membrane vesicle vaccine MenBvac
|
Caron, François
|
|
2012
|
30 |
Supplement 1 |
p. 5059-5062
4 p.
|
artikel
|
| 103 |
Factors influencing pandemic influenza vaccination of healthcare workers—A systematic review
|
Prematunge, Chatura
|
|
2012
|
30 |
Supplement 1 |
p. 4733-4743
11 p.
|
artikel
|
| 104 |
Failure of the vaccination campaign against A(H1N1) influenza in pregnant women in France: Results from a national survey
|
Blondel, Béatrice
|
|
2012
|
30 |
Supplement 1 |
p. 5661-5665
5 p.
|
artikel
|
| 105 |
Feasibility of a randomized controlled trial to evaluate Text Reminders for Immunization Compliance in Kids (TRICKs)
|
Ahlers-Schmidt, Carolyn R.
|
|
2012
|
30 |
Supplement 1 |
p. 5305-5309
5 p.
|
artikel
|
| 106 |
Financing vaccinations – The South African experience
|
Blecher, Mark S.
|
|
2012
|
30 |
Supplement 1 |
p. C79-C86
nvt p.
|
artikel
|
| 107 |
Focus and breadth of cellular immune responses elicited by a heterologous insert prime-boost vaccine regimen in rhesus monkeys
|
Kaufman, David R.
|
|
2012
|
30 |
Supplement 1 |
p. 506-509
4 p.
|
artikel
|
| 108 |
GAVI Report
|
|
|
2012
|
30 |
Supplement 1 |
p. D1-D83
nvt p.
|
artikel
|
| 109 |
Genome-wide association study of antibody response to smallpox vaccine
|
Ovsyannikova, Inna G.
|
|
2012
|
30 |
Supplement 1 |
p. 4182-4189
8 p.
|
artikel
|
| 110 |
Geographic differentiation of polymorphism in the Plasmodium falciparum malaria vaccine candidate gene SERA5
|
Tanabe, Kazuyuki
|
|
2012
|
30 |
Supplement 1 |
p. 1583-1593
11 p.
|
artikel
|
| 111 |
Haemophilus influenzae type b conjugate vaccines – A South African perspective
|
Visser, Adele
|
|
2012
|
30 |
Supplement 1 |
p. C52-C57
nvt p.
|
artikel
|
| 112 |
Healthcare workers and H1N1 vaccination: Does having a chronic disease make a difference?
|
Toh, Matthias Paul Han Sim
|
|
2012
|
30 |
Supplement 1 |
p. 1064-1070
7 p.
|
artikel
|
| 113 |
Health economics of rotavirus immunization in Vietnam: Potentials for favorable cost-effectiveness in developing countries
|
Tu, Hong-Anh T.
|
|
2012
|
30 |
Supplement 1 |
p. 1521-1528
8 p.
|
artikel
|
| 114 |
Hepatitis B vaccination of susceptible elderly residents of long term care facilities during a hepatitis B outbreak
|
Williams, Roxanne E.
|
|
2012
|
30 |
Supplement 1 |
p. 3147-3150
4 p.
|
artikel
|
| 115 |
Hepatitis B virus carrier rate, prevalence and susceptibility and impact of immunization program among households in the city of Taiz, Yemen
|
Sallam, T.A.
|
|
2012
|
30 |
Supplement 1 |
p. 5564-5568
5 p.
|
artikel
|
| 116 |
Heteroclitic peptides enhance human immunodeficiency virus-specific CD8+ T cell responses
|
Gladney, Krista H.
|
|
2012
|
30 |
Supplement 1 |
p. 6997-7004
8 p.
|
artikel
|
| 117 |
Heterologous prime-boost regimen adenovector 35-circumsporozoite protein vaccine/recombinant Bacillus Calmette-Guérin expressing the Plasmodium falciparum circumsporozoite induces enhanced long-term memory immunity in BALB/c mice
|
Arama, Charles
|
|
2012
|
30 |
Supplement 1 |
p. 4040-4045
6 p.
|
artikel
|
| 118 |
HIV-1 and influenza antigens synthetically linked to IgG2a Fc elicit superior humoral responses compared to unmodified antigens in mice
|
Zaharatos, Gerasimos J.
|
|
2011
|
30 |
Supplement 1 |
p. 42-50
9 p.
|
artikel
|
| 119 |
HIV vaccine candidates generate in vitro T cell response to putative epitopes in Chinese-origin rhesus macaques
|
Liao, Qi
|
|
2012
|
30 |
Supplement 1 |
p. 1601-1608
8 p.
|
artikel
|
| 120 |
HLA class II restriction of HIV-1 clade-specific neutralizing antibody responses in ethnic Thai recipients of the RV144 prime-boost vaccine combination of ALVAC-HIV and AIDSVAX® B/E
|
Paris, Robert
|
|
2012
|
30 |
Supplement 1 |
p. 832-836
5 p.
|
artikel
|
| 121 |
Homologous whole bacterin vaccination is not able to reduce Streptococcus suis serotype 9 strain 7997 transmission among pigs or colonization
|
Dekker, C.N.T.
|
|
2012
|
30 |
Supplement 1 |
p. 1379-1387
9 p.
|
artikel
|
| 122 |
Host immune response to A(H1N1)pdm09 vaccination and infection: A one-year prospective study on six cohorts of subjects
|
Liu, Wei
|
|
2012
|
30 |
Supplement 1 |
p. 4785-4789
5 p.
|
artikel
|
| 123 |
How influenza vaccination policy may affect vaccine logistics
|
Assi, Tina-Marie
|
|
2012
|
30 |
Supplement 1 |
p. 4517-4523
7 p.
|
artikel
|
| 124 |
Human papillomavirus, lichen sclerosus and penile cancer: A study in Belgium
|
D’Hauwers, K.W.M.
|
|
2012
|
30 |
Supplement 1 |
p. 6573-6577
5 p.
|
artikel
|
| 125 |
Humoral and cellular immune response generated by different vaccine programs before and after Salmonella Enteritidis challenge in chickens
|
Penha Filho, Rafael Antonio Casarin
|
|
2012
|
30 |
Supplement 1 |
p. 7637-7643
7 p.
|
artikel
|
| 126 |
Humoral immunity 10 years after booster immunization with an adolescent and adult formulation combined tetanus, diphtheria, and 5-component acellular pertussis vaccine
|
Tomovici, A.
|
|
2012
|
30 |
Supplement 1 |
p. 2647-2653
7 p.
|
artikel
|
| 127 |
Identification and characterization of Borrelia antigens as potential vaccine candidates against Lyme borreliosis
|
Poljak, Albina
|
|
2012
|
30 |
Supplement 1 |
p. 4398-4406
9 p.
|
artikel
|
| 128 |
Identification of B- and T-cell epitopes from glycoprotein B of herpes simplex virus 2 and evaluation of their immunogenicity and protection efficacy
|
Liu, Kun
|
|
2012
|
30 |
Supplement 1 |
p. 3034-3041
8 p.
|
artikel
|
| 129 |
Immunity to Staphylococcus aureus secreted proteins protects rabbits from serious illnesses
|
Spaulding, Adam R.
|
|
2012
|
30 |
Supplement 1 |
p. 5099-5109
11 p.
|
artikel
|
| 130 |
Immunity to tetanus and diphtheria in the UK in 2009
|
Wagner, Karen S.
|
|
2012
|
30 |
Supplement 1 |
p. 7111-7117
7 p.
|
artikel
|
| 131 |
Immunization coverage and timeliness of vaccination in Italian children with chronic diseases
|
Pandolfi, E.
|
|
2012
|
30 |
Supplement 1 |
p. 5172-5178
7 p.
|
artikel
|
| 132 |
Immunization with the RrgB321 fusion protein protects mice against both high and low pilus-expressing Streptococcus pneumoniae populations
|
Moschioni, Monica
|
|
2012
|
30 |
Supplement 1 |
p. 1349-1356
8 p.
|
artikel
|
| 133 |
Immunogenicity and efficacy of chimeric dengue vaccine (DENVax) formulations in interferon-deficient AG129 mice
|
Brewoo, Joseph N.
|
|
2012
|
30 |
Supplement 1 |
p. 1513-1520
8 p.
|
artikel
|
| 134 |
Immunogenicity and protective efficacy of a vaxfectin-adjuvanted tetravalent dengue DNA vaccine
|
Porter, Kevin R.
|
|
2012
|
30 |
Supplement 1 |
p. 336-341
6 p.
|
artikel
|
| 135 |
Immunogenicity and safety of a two-dose regimen of a combined measles, mumps, rubella and varicella live vaccine (ProQuad®) in infants from 9 months of age
|
Vesikari, Timo
|
|
2012
|
30 |
Supplement 1 |
p. 3082-3089
8 p.
|
artikel
|
| 136 |
Immunogenicity and safety of a 13-valent pneumococcal conjugate vaccine given with routine pediatric vaccines in Taiwan
|
Huang, Li-Min
|
|
2012
|
30 |
Supplement 1 |
p. 2054-2059
6 p.
|
artikel
|
| 137 |
Immunogenicity and safety of inactivated monovalent 2009 H1N1 influenza A vaccine in immunocompromised children and young adults
|
Hakim, Hana
|
|
2012
|
30 |
Supplement 1 |
p. 879-885
7 p.
|
artikel
|
| 138 |
Immunogenicity and safety of tetravalent dengue vaccine in 2–11 year-olds previously vaccinated against yellow fever: Randomized, controlled, phase II study in Piura, Peru
|
Lanata, Claudio F.
|
|
2012
|
30 |
Supplement 1 |
p. 5935-5941
7 p.
|
artikel
|
| 139 |
Immunogenicity of Infanrix™ hexa administered at 3, 5 and 11 months of age
|
Van Der Meeren, Olivier
|
|
2012
|
30 |
Supplement 1 |
p. 2710-2714
5 p.
|
artikel
|
| 140 |
Immunogenicity of one dose of Vero cell culture-derived Japanese encephalitis (JE) vaccine in adults previously vaccinated with mouse brain-derived JE vaccine
|
Woolpert, Tabitha
|
|
2012
|
30 |
Supplement 1 |
p. 3090-3096
7 p.
|
artikel
|
| 141 |
Immunogenicity of the pentavalent rotavirus vaccine in African infants
|
Armah, George E.
|
|
2012
|
30 |
Supplement 1 |
p. A86-A93
nvt p.
|
artikel
|
| 142 |
Immunogenicity, safety and tolerability of MF59-adjuvanted seasonal influenza vaccine in children with juvenile idiopathic arthritis
|
Dell’Era, Laura
|
|
2012
|
30 |
Supplement 1 |
p. 936-940
5 p.
|
artikel
|
| 143 |
Immunological impact of an additional early measles vaccine in Gambian children: Responses to a boost at 3 years
|
Njie-Jobe, Jainaba
|
|
2012
|
30 |
Supplement 1 |
p. 2543-2550
8 p.
|
artikel
|
| 144 |
Impact of pneumococcal conjugate vaccines on burden of invasive pneumococcal disease and serotype distribution of Streptococcus pneumoniae isolates: An overview from Kuwait
|
Mokaddas, Eiman
|
|
2012
|
30 |
Supplement 1 |
p. G37-G40
nvt p.
|
artikel
|
| 145 |
Impact of pneumococcal vaccination in Denmark during the first 3 years after PCV introduction in the childhood immunization programme
|
Ingels, Helene
|
|
2012
|
30 |
Supplement 1 |
p. 3944-3950
7 p.
|
artikel
|
| 146 |
Impacts on influenza A(H1N1)pdm09 infection from cross-protection of seasonal trivalent influenza vaccines and A(H1N1)pdm09 vaccines: Systematic review and meta-analyses
|
Yin, Jiehui Kevin
|
|
2012
|
30 |
Supplement 1 |
p. 3209-3222
14 p.
|
artikel
|
| 147 |
Improved neutralizing antibody response in the second season after a single dose of pandemic (H1N1) 2009 influenza vaccine in HIV-1-positive adults
|
Kikuchi, Tadashi
|
|
2012
|
30 |
Supplement 1 |
p. 3819-3823
5 p.
|
artikel
|
| 148 |
Inactivated HSV-2 in MPL/alum adjuvant provides nearly complete protection against genital infection and shedding following long term challenge and rechallenge
|
Morello, Christopher S.
|
|
2012
|
30 |
Supplement 1 |
p. 6541-6550
10 p.
|
artikel
|
| 149 |
Inclusion of a CRF01_AE HIV envelope protein boost with a DNA/MVA prime-boost vaccine: Impact on humoral and cellular immunogenicity and viral load reduction after SHIV-E challenge
|
Cox, Josephine H.
|
|
2012
|
30 |
Supplement 1 |
p. 1830-1840
11 p.
|
artikel
|
| 150 |
Increasing adolescent immunization by webinar: A brief provider intervention at federally qualified health centers
|
Moss, Jennifer L.
|
|
2012
|
30 |
Supplement 1 |
p. 4960-4963
4 p.
|
artikel
|
| 151 |
Indicators of therapeutic effect in FIT-06, a Phase II trial of a DNA vaccine, GTU®-Multi-HIVB, in untreated HIV-1 infected subjects
|
Vardas, Eftyhia
|
|
2012
|
30 |
Supplement 1 |
p. 4046-4054
9 p.
|
artikel
|
| 152 |
Induction of a protective immune response to rabies virus in sheep after oral immunization with transgenic maize, expressing the rabies virus glycoprotein
|
Loza-Rubio, Elizabeth
|
|
2012
|
30 |
Supplement 1 |
p. 5551-5556
6 p.
|
artikel
|
| 153 |
Intrinsic adjuvanting of a novel single-cycle flavivirus vaccine in the absence of type I interferon receptor signaling
|
Winkelmann, Evandro R.
|
|
2012
|
30 |
Supplement 1 |
p. 1465-1475
11 p.
|
artikel
|
| 154 |
Killed Bacillus subtilis spores as a mucosal adjuvant for an H5N1 vaccine
|
Song, Manki
|
|
2012
|
30 |
Supplement 1 |
p. 3266-3277
12 p.
|
artikel
|
| 155 |
Liposomal SLA co-incorporated with PO CpG ODNs or PS CpG ODNs induce the same protection against the murine model of leishmaniasis
|
Shargh, Vahid Heravi
|
|
2012
|
30 |
Supplement 1 |
p. 3957-3964
8 p.
|
artikel
|
| 156 |
Lymphocyte-polarized dendritic cells are highly effective in inducing tumor-specific CTLs
|
Berk, Erik
|
|
2012
|
30 |
Supplement 1 |
p. 6216-6224
9 p.
|
artikel
|
| 157 |
Malnutrition levels among vaccinated and unvaccinated children between 2 and 3 years of age following enrollment in a randomized clinical trial with the pentavalent rotavirus vaccine (PRV) in Bangladesh
|
Feller, Andrea J.
|
|
2012
|
30 |
Supplement 1 |
p. A101-A105
nvt p.
|
artikel
|
| 158 |
Maternal knowledge, attitudes and beliefs regarding gastroenteritis and rotavirus vaccine before implementing vaccination program: Which key messages in light of a new immunization program?
|
Morin, Alyssa
|
|
2012
|
30 |
Supplement 1 |
p. 5921-5927
7 p.
|
artikel
|
| 159 |
Measles outbreak in Burkina Faso, 2009: A case–control study to determine risk factors and estimate vaccine effectiveness
|
Kidd, Sarah
|
|
2012
|
30 |
Supplement 1 |
p. 5000-5008
9 p.
|
artikel
|
| 160 |
Measuring bovine viral diarrhea virus vaccine response: Using a commercially available ELISA as a surrogate for serum neutralization assays
|
Gonda, M.G.
|
|
2012
|
30 |
Supplement 1 |
p. 6559-6563
5 p.
|
artikel
|
| 161 |
Measuring people's knowledge about vaccination: Developing a one-dimensional scale
|
Zingg, Alexandra
|
|
2012
|
30 |
Supplement 1 |
p. 3771-3777
7 p.
|
artikel
|
| 162 |
Meningococcal disease from the public health policy perspective
|
Black, Steven B.
|
|
2012
|
30 |
Supplement 1 |
p. B37-B39
nvt p.
|
artikel
|
| 163 |
Meningococcal vaccine development – from glycoconjugates against MenACWY to proteins against MenB – potential for broad protection against meningococcal disease
|
Dull, Peter M.
|
|
2012
|
30 |
Supplement 1 |
p. B18-B25
nvt p.
|
artikel
|
| 164 |
Merozoite surface protein-1 of Plasmodium yoelii fused via an oligosaccharide moiety of cholera toxin B subunit glycoprotein expressed in yeast induced protective immunity against lethal malaria infection in mice
|
Miyata, Takeshi
|
|
2012
|
30 |
Supplement 1 |
p. 948-958
11 p.
|
artikel
|
| 165 |
Methodology and lessons-learned from the efficacy clinical trial of the pentavalent rotavirus vaccine in Bangladesh
|
Zaman, K.
|
|
2012
|
30 |
Supplement 1 |
p. A94-A100
nvt p.
|
artikel
|
| 166 |
Modelling the long-term persistence of neutralizing antibody in adults after one dose of live attenuated Japanese encephalitis chimeric virus vaccine
|
Desai, Kamal
|
|
2012
|
30 |
Supplement 1 |
p. 2510-2515
6 p.
|
artikel
|
| 167 |
Molecular characterization of rotavirus strains detected during a clinical trial of a human rotavirus vaccine in Blantyre, Malawi
|
Nakagomi, Toyoko
|
|
2012
|
30 |
Supplement 1 |
p. A140-A151
nvt p.
|
artikel
|
| 168 |
Monitoring adverse events following immunization with a new conjugate vaccine against group A meningococcus in Niger, September 2010
|
Chaibou, Maman S.
|
|
2012
|
30 |
Supplement 1 |
p. 5229-5234
6 p.
|
artikel
|
| 169 |
Monitoring of rotavirus vaccination in Morocco: Establishing the baseline burden of rotavirus disease
|
Benhafid, Mohammed
|
|
2012
|
30 |
Supplement 1 |
p. 6515-6520
6 p.
|
artikel
|
| 170 |
Motif-optimized subtype A HIV envelope-based DNA vaccines rapidly elicit neutralizing antibodies when delivered sequentially
|
Pissani, Franco
|
|
2012
|
30 |
Supplement 1 |
p. 5519-5526
8 p.
|
artikel
|
| 171 |
Mucosal vaccination increases local chemokine production attracting immune cells to the stomach mucosa of Helicobacter pylori infected mice
|
Flach, Carl-Fredrik
|
|
2012
|
30 |
Supplement 1 |
p. 1636-1643
8 p.
|
artikel
|
| 172 |
Multilevel correlates for human papillomavirus vaccination of adolescent girls attending safety net clinics
|
Tiro, Jasmin A.
|
|
2012
|
30 |
Supplement 1 |
p. 2368-2375
8 p.
|
artikel
|
| 173 |
Mumps: Burden of disease in France
|
Coffinières, E.
|
|
2012
|
30 |
Supplement 1 |
p. 7013-7018
6 p.
|
artikel
|
| 174 |
Mycobacterium indicus pranii mediates macrophage activation through TLR2 and NOD2 in a MyD88 dependent manner
|
Pandey, Rajeev Kumar
|
|
2012
|
30 |
Supplement 1 |
p. 5748-5754
7 p.
|
artikel
|
| 175 |
NDV-3, a recombinant alum-adjuvanted vaccine for Candida and Staphylococcus aureus, is safe and immunogenic in healthy adults
|
Schmidt, Clint S.
|
|
2012
|
30 |
Supplement 1 |
p. 7594-7600
7 p.
|
artikel
|
| 176 |
Neonatal revaccination with Bacillus Calmette–Guérin elicits improved, early protection against Mycobacterium tuberculosis in mice
|
Li, Wen
|
|
2012
|
30 |
Supplement 1 |
p. 3223-3230
8 p.
|
artikel
|
| 177 |
Non-susceptibility trends and serotype coverage by conjugate pneumococcal vaccines in a Tunisian paediatric population: A 10-year study
|
Charfi, F.
|
|
2012
|
30 |
Supplement 1 |
p. G18-G24
nvt p.
|
artikel
|
| 178 |
Novel CD8+ T cell-based vaccine stimulates Gp120-specific CTL responses leading to therapeutic and long-term immunity in transgenic HLA-A2 mice
|
Nanjundappa, Roopa Hebbandi
|
|
2012
|
30 |
Supplement 1 |
p. 3519-3525
7 p.
|
artikel
|
| 179 |
One clinic visit for pre-exposure rabies vaccination (a preliminary one year study)
|
Khawplod, Pakamatz
|
|
2012
|
30 |
Supplement 1 |
p. 2918-2920
3 p.
|
artikel
|
| 180 |
Oral administration of allergen extracts from mugwort pollen desensitizes specific allergen-induced allergy in mice
|
Ma, Wen-Jiang
|
|
2012
|
30 |
Supplement 1 |
p. 1437-1444
8 p.
|
artikel
|
| 181 |
Oral administration of HPV-16 L2 displayed on Lactobacillus casei induces systematic and mucosal cross-neutralizing effects in Balb/c mice
|
Yoon, Sun-Woo
|
|
2012
|
30 |
Supplement 1 |
p. 3286-3294
9 p.
|
artikel
|
| 182 |
Parental and societal values for the risks and benefits of childhood combination vaccines
|
Gidengil, Courtney
|
|
2012
|
30 |
Supplement 1 |
p. 3445-3452
8 p.
|
artikel
|
| 183 |
Pertussis vaccination in infancy lowers the incidence of pertussis disease and the rate of hospitalisation after one and two doses: Analyses of 10 years of pertussis surveillance
|
Nilsson, Lennart
|
|
2012
|
30 |
Supplement 1 |
p. 3239-3247
9 p.
|
artikel
|
| 184 |
Phase III, randomized controlled trial to evaluate lot consistency of a trivalent subunit egg-based influenza vaccine in adults
|
Rivera, Luis
|
|
2012
|
30 |
Supplement 1 |
p. 5285-5292
8 p.
|
artikel
|
| 185 |
Phase I study of a Neisseria meningitidis liposomal vaccine containing purified outer membrane proteins and detoxified lipooligosaccharide
|
Zollinger, Wendell D.
|
|
2012
|
30 |
Supplement 1 |
p. 712-721
10 p.
|
artikel
|
| 186 |
Phosphatidylinositol di-mannoside and derivates modulate the immune response to and efficacy of a tuberculosis protein vaccine against Mycobacterium bovis infection
|
Parlane, Natalie A.
|
|
2012
|
30 |
Supplement 1 |
p. 580-588
9 p.
|
artikel
|
| 187 |
Pneumococcal serotype distribution among meningitis cases from Togo and Burkina Faso during 2007–2009
|
Gessner, Bradford D.
|
|
2012
|
30 |
Supplement 1 |
p. G41-G45
nvt p.
|
artikel
|
| 188 |
Pneumococcal vaccines WHO position paper – 2012 – Recommendations
|
WHO Publication,
|
|
2012
|
30 |
Supplement 1 |
p. 4717-4718
2 p.
|
artikel
|
| 189 |
Population-based surveillance for invasive pneumococcal disease and pneumonia in infants and young children in Bogotá, Colombia
|
Benavides, Juan Alberto
|
|
2012
|
30 |
Supplement 1 |
p. 5886-5892
7 p.
|
artikel
|
| 190 |
Potential serotype coverage of three pneumococcal conjugate vaccines against invasive pneumococcal infection in Italian children
|
Azzari, Chiara
|
|
2012
|
30 |
Supplement 1 |
p. 2701-2705
5 p.
|
artikel
|
| 191 |
Preclinical safety assessment of recombinant botulinum vaccine A/B (rBV A/B)
|
Shearer, Jeffry D.
|
|
2012
|
30 |
Supplement 1 |
p. 1917-1926
10 p.
|
artikel
|
| 192 |
Preclinical safety evaluation of DNA vaccines encoding modified HPV16 E6 and E7
|
Henken, F.E.
|
|
2012
|
30 |
Supplement 1 |
p. 4259-4266
8 p.
|
artikel
|
| 193 |
Prevalence of Streptococcus pneumoniae serotypes causing invasive and non-invasive disease in South East Asia: A review
|
Jauneikaite, E.
|
|
2012
|
30 |
Supplement 1 |
p. 3503-3514
12 p.
|
artikel
|
| 194 |
Prime boost vaccination approaches with different conjugates of a new HIV-1 gp41 epitope encompassing the membrane proximal external region induce neutralizing antibodies in mice
|
Zhou, Mingkui
|
|
2012
|
30 |
Supplement 1 |
p. 1911-1916
6 p.
|
artikel
|
| 195 |
Process optimization and scale-up for production of rabies vaccine live adenovirus vector (AdRG1.3)
|
Shen, Chun Fang
|
|
2012
|
30 |
Supplement 1 |
p. 300-306
7 p.
|
artikel
|
| 196 |
Prospective epidemiologic surveillance of invasive pneumococcal disease and pneumonia in children in San José, Costa Rica
|
Arguedas, Adriano
|
|
2012
|
30 |
Supplement 1 |
p. 2342-2348
7 p.
|
artikel
|
| 197 |
Protective efficacy of Bluetongue virus-like and subvirus-like particles in sheep: Presence of the serotype-specific VP2, independent of its geographic lineage, is essential for protection
|
Stewart, M.
|
|
2012
|
30 |
Supplement 1 |
p. 2131-2139
9 p.
|
artikel
|
| 198 |
Protective immunity to DENV2 after immunization with a recombinant NS1 protein using a genetically detoxified heat-labile toxin as an adjuvant
|
Amorim, Jaime Henrique
|
|
2012
|
30 |
Supplement 1 |
p. 837-845
9 p.
|
artikel
|
| 199 |
Public health and economic impact of 13-valent pneumococcal conjugate vaccine in US adults aged ≥50years
|
Weycker, Derek
|
|
2012
|
30 |
Supplement 1 |
p. 5437-5444
8 p.
|
artikel
|
| 200 |
Public health impact of including two lineages of influenza B in a quadrivalent seasonal influenza vaccine
|
Reed, Carrie
|
|
2012
|
30 |
Supplement 1 |
p. 1993-1998
6 p.
|
artikel
|
| 201 |
Rapid reduction in invasive pneumococcal disease after introduction of PCV7 into the National Immunization Plan in Israel
|
Ben-Shimol, S.
|
|
2012
|
30 |
Supplement 1 |
p. 6600-6607
8 p.
|
artikel
|
| 202 |
Re-circulation of lymphocytes mediated by sphingosine-1-phosphate receptor-1 contributes to resistance against experimental infection with the protozoan parasite Trypanosoma cruzi
|
Dominguez, Mariana R.
|
|
2012
|
30 |
Supplement 1 |
p. 2882-2891
10 p.
|
artikel
|
| 203 |
Reframing Cervical Cancer Prevention. Expanding the Field Towards Prevention of Human Papillomavirus Infections and Related Diseases
|
Bosch, F. Xavier
|
|
2012
|
30 |
Supplement 1 |
p. F1-F11
nvt p.
|
artikel
|
| 204 |
Repeated dose intramuscular injection of the CIMAvax-EGF vaccine in Sprague Dawley rats induces local and systemic toxicity
|
Mancebo, A.
|
|
2012
|
30 |
Supplement 1 |
p. 3329-3338
10 p.
|
artikel
|
| 205 |
Report of the ad-hoc consultation on aging and immunization for a future WHO research agenda on life-course immunization
|
Thomas-Crusells, Judith
|
|
2012
|
30 |
Supplement 1 |
p. 6007-6012
6 p.
|
artikel
|
| 206 |
Reprint of: Serotyping and antibiotic susceptibility of Streptococcus pneumoniae strains isolated in Algeria from 2001 to 2010
|
Tali-Maamar, H.
|
|
2012
|
30 |
Supplement 1 |
p. G25-G31
nvt p.
|
artikel
|
| 207 |
Research priorities for global measles and rubella control and eradication
|
Goodson, James L.
|
|
2012
|
30 |
Supplement 1 |
p. 4709-4716
8 p.
|
artikel
|
| 208 |
Research priorities regarding rotavirus vaccine and intussusception: A meeting summary
|
Tate, Jacqueline E.
|
|
2012
|
30 |
Supplement 1 |
p. A179-A184
nvt p.
|
artikel
|
| 209 |
Respiratory viruses transmission from children to adults within a household
|
MacIntyre, Chandini Raina
|
|
2012
|
30 |
Supplement 1 |
p. 3009-3014
6 p.
|
artikel
|
| 210 |
Retrospective hospital based surveillance of intussusception in children in a sentinel paediatric hospital: Benefits and pitfalls for use in post-marketing surveillance of rotavirus vaccines
|
Lloyd-Johnsen, C.
|
|
2012
|
30 |
Supplement 1 |
p. A190-A195
nvt p.
|
artikel
|
| 211 |
Revaccination with Fendrix® or HBVaxPro® results in better response rates than does revaccination with three doses of Engerix-B® in previous non-responders
|
Hoebe, Christian J.P.A.
|
|
2012
|
30 |
Supplement 1 |
p. 6734-6737
4 p.
|
artikel
|
| 212 |
Risk factors associated with parents claiming personal-belief exemptions to school immunization requirements: Community and other influences on more skeptical parents in Oregon, 2006
|
Gaudino, James A.
|
|
2012
|
30 |
Supplement 1 |
p. 1132-1142
11 p.
|
artikel
|
| 213 |
Rotavirus vaccine RIX4414 efficacy sustained during the third year of life: A randomized clinical trial in an Asian population
|
Phua, Kong Boo
|
|
2012
|
30 |
Supplement 1 |
p. 4552-4557
6 p.
|
artikel
|
| 214 |
Rotavirus vaccine series completion and adherence to vaccination schedules among infants in managed care in the United States
|
Krishnarajah, Girishanthy
|
|
2012
|
30 |
Supplement 1 |
p. 3717-3722
6 p.
|
artikel
|
| 215 |
Safety and immunogenicity of a 2009 influenza A (H1N1) vaccine in hemodialysis patients
|
Lertdumrongluk, Paungpaga
|
|
2012
|
30 |
Supplement 1 |
p. 1108-1114
7 p.
|
artikel
|
| 216 |
Safety and immunogenicity of a modified process hepatitis B vaccine in healthy neonates
|
Minervini, Gianmaria
|
|
2012
|
30 |
Supplement 1 |
p. 1476-1480
5 p.
|
artikel
|
| 217 |
Safety and immunogenicity of an MF59®-adjuvanted A/H5N1 pre-pandemic influenza vaccine in adults and the elderly
|
Vesikari, Timo
|
|
2012
|
30 |
Supplement 1 |
p. 1388-1396
9 p.
|
artikel
|
| 218 |
Safety and immunogenicity of a pneumococcal histidine triad protein D vaccine candidate in adults
|
Seiberling, Michael
|
|
2012
|
30 |
Supplement 1 |
p. 7455-7460
6 p.
|
artikel
|
| 219 |
Safety and immunogenicity of a vaccine targeting human papillomavirus types 6, 11, 16 and 18: A randomized, double-blind, placebo-controlled trial in Chinese males and females
|
Li, Rongcheng
|
|
2012
|
30 |
Supplement 1 |
p. 4284-4291
8 p.
|
artikel
|
| 220 |
Safety and immunogenicity of 2010–2011 H1N12009-containing trivalent inactivated influenza vaccine in children 12–59 months of age previously given AS03-adjuvanted H1N12009 pandemic vaccine: A PHAC/CIHR Influenza Research Network (PCIRN) study
|
Langley, Joanne M.
|
|
2012
|
30 |
Supplement 1 |
p. 3389-3394
6 p.
|
artikel
|
| 221 |
Safety and immunogenicity of pneumococcal protein vaccine candidates: Monovalent choline-binding protein A (PcpA) vaccine and bivalent PcpA–pneumococcal histidine triad protein D vaccine
|
Bologa, Monica
|
|
2012
|
30 |
Supplement 1 |
p. 7461-7468
8 p.
|
artikel
|
| 222 |
Safety and immunogenicity of two different doses of a Vero cell-derived, whole virus clade 2 H5N1 (A/Indonesia/05/2005) influenza vaccine
|
Tambyah, Paul A.
|
|
2012
|
30 |
Supplement 1 |
p. 329-335
7 p.
|
artikel
|
| 223 |
Safety and pharmacokinetics of a human monoclonal antibody to rabies virus: A randomized, dose-escalation phase 1 study in adults
|
Gogtay, Nithya
|
|
2012
|
30 |
Supplement 1 |
p. 7315-7320
6 p.
|
artikel
|
| 224 |
Safety of live, attenuated oral vaccines in HIV-infected Zambian adults
|
Banda, Rose
|
|
2012
|
30 |
Supplement 1 |
p. 5656-5660
5 p.
|
artikel
|
| 225 |
Safety, tolerability, and immunogenicity after 1 and 2 doses of zoster vaccine in healthy adults ≥60 years of age
|
Vermeulen, Joost N.
|
|
2012
|
30 |
Supplement 1 |
p. 904-910
7 p.
|
artikel
|
| 226 |
Salmonella typhi Ty21a bacterial ghost vector augments HIV-1 gp140 DNA vaccine-induced peripheral and mucosal antibody responses via TLR4 pathway
|
Wen, Jing
|
|
2012
|
30 |
Supplement 1 |
p. 5733-5739
7 p.
|
artikel
|
| 227 |
School-located influenza immunization programs: Factors important to parents and students
|
Middleman, Amy B.
|
|
2012
|
30 |
Supplement 1 |
p. 4993-4999
7 p.
|
artikel
|
| 228 |
Sendai virus-based RSV vaccine protects African green monkeys from RSV infection
|
Jones, Bart G.
|
|
2012
|
30 |
Supplement 1 |
p. 959-968
10 p.
|
artikel
|
| 229 |
Seroprevalence of poliovirus antibodies amongst children in Zaria, Northern Nigeria
|
Giwa, F.J.
|
|
2012
|
30 |
Supplement 1 |
p. 6759-6765
7 p.
|
artikel
|
| 230 |
Serotype changes in adult invasive pneumococcal infections in Portugal did not reduce the high fraction of potentially vaccine preventable infections
|
Horácio, Andreia N.
|
|
2012
|
30 |
Supplement 1 |
p. 218-224
7 p.
|
artikel
|
| 231 |
Signal identification and evaluation for risk of febrile seizures in children following trivalent inactivated influenza vaccine in the Vaccine Safety Datalink Project, 2010–2011
|
Tse, Alison
|
|
2012
|
30 |
Supplement 1 |
p. 2024-2031
8 p.
|
artikel
|
| 232 |
Simplifying complex sequence information: A PCP-consensus protein binds antibodies against all four Dengue serotypes
|
Bowen, David M.
|
|
2012
|
30 |
Supplement 1 |
p. 6081-6087
7 p.
|
artikel
|
| 233 |
Soluble multi-trimeric TNF superfamily ligand adjuvants enhance immune responses to a HIV-1 Gag DNA vaccine
|
Kanagavelu, Saravana K.
|
|
2012
|
30 |
Supplement 1 |
p. 691-702
12 p.
|
artikel
|
| 234 |
Stability of a formalin-inactivated Rift Valley fever vaccine: Evaluation of a vaccination campaign for cattle in Mozambique
|
Lagerqvist, N.
|
|
2012
|
30 |
Supplement 1 |
p. 6534-6540
7 p.
|
artikel
|
| 235 |
Strain impact on equine herpesvirus type 1 (EHV-1) abortion models: Viral loads in fetal and placental tissues and foals
|
Gardiner, David W.
|
|
2012
|
30 |
Supplement 1 |
p. 6564-6572
9 p.
|
artikel
|
| 236 |
Sustained viral load reduction in treatment-naive HCV genotype 1 infected patients after therapeutic peptide vaccination
|
Klade, Christoph S.
|
|
2012
|
30 |
Supplement 1 |
p. 2943-2950
8 p.
|
artikel
|
| 237 |
The association of seasonal influenza vaccination with pandemic influenza H1N1 2009 infection
|
Kelly, Heath
|
|
2012
|
30 |
Supplement 1 |
p. 2037-2038
2 p.
|
artikel
|
| 238 |
The cationic lipid, diC14 amidine, extends the adjuvant properties of aluminum salts through a TLR-4- and caspase-1-independent mechanism
|
Wilmar, Arnaud
|
|
2012
|
30 |
Supplement 1 |
p. 414-424
11 p.
|
artikel
|
| 239 |
The efficacy of intranasal live attenuated influenza vaccine in children 2 through 17 years of age: A meta-analysis of 8 randomized controlled studies
|
Ambrose, Christopher S.
|
|
2012
|
30 |
Supplement 1 |
p. 886-892
7 p.
|
artikel
|
| 240 |
The extradomain A of fibronectin (EDA) combined with poly(I:C) enhances the immune response to HIV-1 p24 protein and the protection against recombinant Listeria monocytogenes-Gag infection in the mouse model
|
San Román, Beatriz
|
|
2012
|
30 |
Supplement 1 |
p. 2564-2569
6 p.
|
artikel
|
| 241 |
The immunogenicity and safety of different formulations of a novel Staphylococcus aureus vaccine (V710): Results of two Phase I studies
|
Harro, Clayton D.
|
|
2012
|
30 |
Supplement 1 |
p. 1729-1736
8 p.
|
artikel
|
| 242 |
The impact of making vaccines thermostable in Niger's vaccine supply chain
|
Lee, Bruce Y.
|
|
2012
|
30 |
Supplement 1 |
p. 5637-5643
7 p.
|
artikel
|
| 243 |
The pediatric vaccine stockpiling problem
|
Truong, Van-Anh
|
|
2012
|
30 |
Supplement 1 |
p. 6175-6179
5 p.
|
artikel
|
| 244 |
The potential economic value of a Staphylococcus aureus vaccine among hemodialysis patients
|
Song, Yeohan
|
|
2012
|
30 |
Supplement 1 |
p. 3675-3682
8 p.
|
artikel
|
| 245 |
The presence of viral subpopulations in an infectious bronchitis virus vaccine with differing pathogenicity – A preliminary study
|
Hewson, Kylie A.
|
|
2012
|
30 |
Supplement 1 |
p. 4190-4199
10 p.
|
artikel
|
| 246 |
The reporting completeness of a passive safety surveillance system for pandemic (H1N1) 2009 vaccines: A capture–recapture analysis
|
Huang, Wan-Ting
|
|
2012
|
30 |
Supplement 1 |
p. 2168-2172
5 p.
|
artikel
|
| 247 |
The role of nasal IgA in children vaccinated with live attenuated influenza vaccine
|
Ambrose, Christopher S.
|
|
2012
|
30 |
Supplement 1 |
p. 6794-6801
8 p.
|
artikel
|
| 248 |
The structure of HBsAg particles is not modified upon their adsorption on aluminium hydroxide gel
|
Greiner, Vanille J.
|
|
2012
|
30 |
Supplement 1 |
p. 5240-5245
6 p.
|
artikel
|
| 249 |
The unmet need in the elderly: How immunosenescence, CMV infection, co-morbidities and frailty are a challenge for the development of more effective influenza vaccines
|
McElhaney, Janet E.
|
|
2012
|
30 |
Supplement 1 |
p. 2060-2067
8 p.
|
artikel
|
| 250 |
Thymosin-alpha 1 (Zadaxin™) enhances the immunogenicity of an adjuvated pandemic H1N1v influenza vaccine (Focetria™) in hemodialyzed patients: A pilot study
|
Carraro, G.
|
|
2012
|
30 |
Supplement 1 |
p. 1170-1180
11 p.
|
artikel
|
| 251 |
Toxoplasma gondii immune mapped protein-1 (TgIMP1) is a novel vaccine candidate against toxoplasmosis
|
Cui, Xia
|
|
2012
|
30 |
Supplement 1 |
p. 2282-2287
6 p.
|
artikel
|
| 252 |
Transcutaneous immunization with Intercell's vaccine delivery system
|
Seid Jr., Robert C.
|
|
2012
|
30 |
Supplement 1 |
p. 4349-4354
6 p.
|
artikel
|
| 253 |
Transfer of the ability of HIV-1 Tat to raise an adjuvant-free humoral immune response to unrelated antigens
|
Gadzinski, Adeline
|
|
2012
|
30 |
Supplement 1 |
p. 2859-2868
10 p.
|
artikel
|
| 254 |
Transmission of a live Eimeria acervulina vaccine strain and response to infection in vaccinated and contact-vaccinated broilers
|
Velkers, Francisca C.
|
|
2012
|
30 |
Supplement 1 |
p. 322-328
7 p.
|
artikel
|
| 255 |
Use of a polyanionic carbomer, Carbopol971P, in combination with MF59, improves antibody responses to HIV-1 envelope glycoprotein
|
Dey, Antu K.
|
|
2012
|
30 |
Supplement 1 |
p. 2749-2759
11 p.
|
artikel
|
| 256 |
Use of human MonoMac6 cells for development of in vitro assay predictive of adjuvant safety in vivo
|
Zaitseva, Marina
|
|
2012
|
30 |
Supplement 1 |
p. 4859-4865
7 p.
|
artikel
|
| 257 |
Use of surveillance data to estimate the effectiveness of the 7-valent conjugate pneumococcal vaccine in children less than 5 years of age over a 9 year period
|
De Serres, Gaston
|
|
2012
|
30 |
Supplement 1 |
p. 4067-4072
6 p.
|
artikel
|
| 258 |
Use of the 13-valent conjugate vaccine has the potential to eliminate pilus carrying isolates as causes of invasive pneumococcal disease
|
Aguiar, Sandra I.
|
|
2012
|
30 |
Supplement 1 |
p. 5487-5490
4 p.
|
artikel
|
| 259 |
UV-inactivated vaccinia virus (VV) in a multi-envelope DNA-VV-protein (DVP) HIV-1 vaccine protects macaques from lethal challenge with heterologous SHIV
|
Jones, Bart G.
|
|
2012
|
30 |
Supplement 1 |
p. 3188-3195
8 p.
|
artikel
|
| 260 |
Vaccination against hepatitis B with 4-double doses increases response rates and antibodies titers in HIV-infected adults
|
Potsch, D.V.
|
|
2012
|
30 |
Supplement 1 |
p. 5973-5977
5 p.
|
artikel
|
| 261 |
Vaccination and acute phase mediator production in chickens challenged with low pathogenic avian influenza virus; novel markers for vaccine efficacy?
|
Sylte, Matthew J.
|
|
2012
|
30 |
Supplement 1 |
p. 3097-3105
9 p.
|
artikel
|
| 262 |
Vaccination and risk of type 1 diabetes mellitus in active component U.S. Military, 2002–2008
|
Duderstadt, Susan K.
|
|
2012
|
30 |
Supplement 1 |
p. 813-819
7 p.
|
artikel
|
| 263 |
Vaccination of chickens with Salmonella Pathogenicity Island (SPI) 1 and SPI2 defective mutants of Salmonella enterica serovar Enteritidis
|
Matulova, M.
|
|
2012
|
30 |
Supplement 1 |
p. 2090-2097
8 p.
|
artikel
|
| 264 |
Vaccination of piglets at 1 week of age with an inactivated Mycoplasma hyopneumoniae vaccine reduces lung lesions and improves average daily gain in body weight
|
Wilson, Stephen
|
|
2012
|
30 |
Supplement 1 |
p. 7625-7629
5 p.
|
artikel
|
| 265 |
Vaccination with BM86, subolesin and akirin protective antigens for the control of tick infestations in white tailed deer and red deer
|
Carreón, Diana
|
|
2012
|
30 |
Supplement 1 |
p. 273-279
7 p.
|
artikel
|
| 266 |
Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis
|
Zhang, L.
|
|
2012
|
30 |
Supplement 1 |
p. 2301-2308
8 p.
|
artikel
|
| 267 |
Vaccination with 3-dose paediatric rotavirus vaccine (RotaTeq®): Impact on the timeliness of uptake of the primary course of DTPa vaccine
|
Wendy, Bissinger
|
|
2012
|
30 |
Supplement 1 |
p. 5293-5297
5 p.
|
artikel
|
| 268 |
Vaccination with Haemophilus influenzae type b conjugate vaccine reduces bacterial meningitis in Morocco
|
Braikat, Mohamed
|
|
2012
|
30 |
Supplement 1 |
p. 2594-2599
6 p.
|
artikel
|
| 269 |
Vaccination with the recombinant chimeric antigen recNcMIC3-1-R induces a non-protective Th2-type immune response in the pregnant mouse model for N. caninum infection
|
Monney, Thierry
|
|
2012
|
30 |
Supplement 1 |
p. 6588-6594
7 p.
|
artikel
|
| 270 |
Vaccine and Immunization Surveillance in Ontario (VISION) – Using linked health administrative databases to monitor vaccine safety
|
Wilson, Kumanan
|
|
2012
|
30 |
Supplement 1 |
p. 6115-6120
6 p.
|
artikel
|
| 271 |
Vaccine induced antibodies to the first variable loop of human immunodeficiency virus type 1 gp120, mediate antibody-dependent virus inhibition in macaques
|
Bialuk, Izabela
|
|
2011
|
30 |
Supplement 1 |
p. 78-94
17 p.
|
artikel
|
Tijdschrift beschrijving